Consumer lending platform Twisto raised $15.6m from investors including ING and Uniqa, bringing its total equity financing to $23.5m.

Midea Real Estate and Red Star Macalline helped Orvibo raise $18.8m of series C capital, taking the smart home technology supplier’s total funding to almost $48m.

Myeg helped increase the AR goggles and software developer's series B round to $32.4m, adding to a $14.9m first tranche backed by Meitu in 2017.

The Intel-backed health product retailer has received $25m from investment firm Sofina in the form of series G funding.

GumGum's dental tools spinoff has raised $11m from Craft Ventures and undisclosed strategic dental industry partners.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Johnson & Johnson, Novartis and Astellas all took part in the first close of a round for oncology therapy developer 28-7 Therapeutics that now stands at $82.8m.

Salesforce Ventures' Canada Trailblazer Fund took part in a $23m round for the commerce services provider that was led by Delta-v Capital.

OUP and Sofinnova Partners invested in 28-7 Therapeutics to take its series A round to $82.8m, enabling the Harvard spinout to pursue accelerated development of its cancer drug pipeline.

BGI's gene sequencer spinoff, MGI Tech, has secured $200m in funding from Goldstone Investment, Green Pine Capital and Orient Securities despite a reported $1bn target.